HempNewsBreaks – MCTC Holdings, Inc. (MCTC) Announces Full Integration of Lelantos Biotech’s Unique Technologies

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, this morning announced the full integration of Lelantos Biotech into MCTC. The company also provided an operational and product introduction update. MCTC announced the acquisition of Lelantos Biotech, Inc. in mid-February. Lelantos Biotech had previously been involved in various areas of cannabinoid and hemp infusion research and had closely collaborated with MCTC in relation to the filing of several patents in numerous hemp extract and cannabinoid delivery technologies. All the developments generated from this collaboration have been assigned to MCTC, and the rights to all six patent pending technologies belong to MCTC. Among other highlights, the update also included further information regarding the integration of the Lelantos technologies, the company’s latest Hemp You Can Feel(TM) products, and the completion of phase one of its Project Varin. “We have now integrated the Lelantos technologies and trade secrets into MCTC Holdings,” MCTC Holdings CEO Arman Tabatabaei stated in the news release. “The manner in which Lelantos was acquired was particularly shareholder-friendly with the owners agreeing to take long term notes in exchange for all of the IP and all rights to the technology. We are now actively integrating these unique and patent pending technologies into several products to be marketed under the Hemp You Can Feel(TM) brand. In all, Lelantos has provided the core technologies allowing us to now have six patents pending. We plan an active announcement and product introduction calendar as we continue to create new products based on these innovations.”

To view the full press release, visit http://cnw.fm/Wjt4H

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the company’s website at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.